Main Uses of Glathion

Glathion, which contains the active ingredient glutathione, is primarily utilized as an antioxidant therapy. It is indicated for use in clinical situations where there is a documented need to address oxidative stress or to provide cytoprotection against toxic metabolites.

Treatment of Liver Disorders

The medication is frequently used in the management of various liver pathologies. Its role involves supporting hepatic function and aiding in the detoxification processes. Specifically, it is applied in cases of:

• Chronic Hepatitis: Assisting in the stabilization of liver enzymes and supporting cellular recovery.
• Liver Cirrhosis: Providing metabolic support to remaining functional liver tissue.
• Fatty Liver Disease (Steatosis): Helping to mitigate oxidative damage within hepatic cells associated with lipid accumulation.
• Toxic Liver Injury: Addressing damage caused by alcohol consumption or exposure to environmental toxins.

Mitigation of Medication-Induced Toxicity

Glathion is utilized to reduce the adverse effects associated with certain pharmacological treatments. It acts as a protective agent for healthy cells during aggressive therapy cycles, particularly in:

• Chemotherapy Support: Helping to reduce the neurotoxicity and nephrotoxicity often associated with specific chemotherapeutic agents.
• Drug-Induced Hepatotoxicity: Counteracting the toxic effects that certain long-term medications may have on liver function.

Benefits and Mechanism of Action

The clinical benefits of Glathion are derived from its role as a major endogenous antioxidant. Its primary physiological contributions include:

Neutralization of Free Radicals

Glathion directly interacts with reactive oxygen species (ROS) and free radicals. By neutralizing these unstable molecules, it prevents lipid peroxidation and protects cellular membranes, DNA, and proteins from oxidative degradation.

Support for Detoxification Pathways

As a substrate for the enzyme glutathione S-transferase, it plays a critical role in Phase II detoxification. It binds to various endogenous and exogenous toxins, transforming them into water-soluble conjugates that can be more easily excreted by the body.

Maintenance of Cellular Redox Balance

Beyond its direct antioxidant activity, it helps maintain other essential antioxidants, such as Vitamin C and Vitamin E, in their active, reduced forms. This contributes to a sustained defense mechanism against cellular stress and supports overall metabolic homeostasis.

Regulatory References

1. Pharmaceuticals and Medical Devices Agency, Japan

Population Eligibility and Contraindications

The eligibility profile for injectable Глатион is strictly defined by official regulatory documentation. Adult Patients who are undergoing specific chemotherapy regimens, such as those involving cisplatin, represent the established and officially allowed user population for this medicine.

The absolute rule for non-eligibility is the presence of known hypersensitivity or allergy to Glutathione (GSH) or any of the injection's components; this formally prohibits use. Beyond this, no other disease-specific absolute contraindications are routinely listed in official summaries.

Use is not recommended in several populations due to insufficient safety data. This restriction applies to both pregnant women and breastfeeding women, for whom use should generally be avoided according to regulatory warnings. Furthermore, general pediatric use (under 18 years of age) is not established as there is a lack of comprehensive safety and efficacy data for this age group.

Finally, national drug authorities explicitly advise against and warn that the use of this injectable medicine for non-therapeutic purposes, such as cosmetic skin lightening, is not approved.

Interactions with other medicines and products

Official regulatory information regarding interactions for Glutathione, often referenced by the trade name Глатион, focuses on its role in detoxification and metabolism of other substances.

Interacting Product Category	Noted Regulatory Interaction Context
Anticancer Drugs (e.g., Cisplatin)	Glutathione is officially documented to interact with Cisplatin, potentially leading to a reduction in the anticancer drug's toxicity on nerves (neurotoxicity).
Analgesics (e.g., Acetaminophen)	High or toxic doses of Acetaminophen (Paracetamol) may severely deplete endogenous Glutathione stores, a crucial detoxification resource in the liver.

Mechanistically, the interaction with high-dose Acetaminophen is defined by the metabolism of the analgesic generating a toxic intermediate that consumes Glutathione for neutralization and excretion. For certain anticancer drugs, the regulatory context notes that Glutathione forms conjugates that facilitate the drug's elimination, thereby reducing its systemic exposure and certain toxicities. No mandatory timing constraints or restrictions, such as 'do not combine' rules, are universally detailed across official documentation for therapeutic use, though clinical context always governs co-administration.

The action of Глатион (Glutathione, GSH) is centered on replenishing a vital endogenous tripeptide by engaging the intrinsic enzymatic and non-enzymatic pathways. Its mechanism involves a dual function: direct chemical scavenging and enzymatic cofactor activity.

---

Direct Neutralization of Cellular Oxidants

This domain covers the direct chemical interaction of GSH with molecular species. Glațion's active thiol group ( -SH) directly neutralizes Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS), such as free radicals and peroxides. This immediate chemical action mitigates the oxidation of critical biomolecules like membrane lipids and DNA. By restoring high concentrations of GSH, the mechanism ensures the rapid maintenance of cellular redox homeostasis, contributing to the maintenance of functional structure.

---

Cofactor Activity in Enzymatic Detoxification and Clearance

The second key domain involves the molecule's role as a necessary cofactor and substrate for the Glutathione S-Transferase (GST) enzyme family. GSTs utilize Glațion to perform a conjugation reaction, chemically tagging electrophilic toxins and endogenous metabolites by making them water-soluble. This process initiates the Mercapturic Acid Pathway, which leads to a sequence resulting in the excretion of these compounds. This mechanism modulates the metabolic clearance processes in tissues like the liver and kidneys.

Administration Overview

Глатион is formulated as a sterile lyophilizate (freeze-dried powder) and is strictly administered via the parenteral route—specifically as an intravenous (IV) infusion or intramuscular (IM) injection. The product is not intended for self-administration and must be prepared and delivered by a qualified healthcare professional. Its use is defined by time-limited courses or cycles, not for continuous, indefinite maintenance.

---

Official Dosing and Scheduling

Official dosing regimens, which may vary by region, are categorized by the context of use. For supportive applications, standard administration ranges from 600 mg to 1200 mg per session. In specific adjunctive uses, the dosage may be calculated based on the patient’s Body Surface Area (BSA), sometimes reaching 1.5 g/m^2 (1500 mg per dose).

Administration frequency is strictly event-driven or cyclic. IV infusions are often timed to occur immediately before the start of a subsequent therapy. IM injections may follow a schedule of administration on specific days of a cycle, or multiple times per week, depending on the therapeutic plan established by the prescribing authority.

---

Preparation Requirements

As a powder, Глатион requires a critical reconstitution step where it is dissolved in a sterile solvent prior to use. For IV administration, the reconstituted solution must undergo further dilution into a larger volume of a compatible infusion solution. This procedural necessity ensures the solution is correctly prepared for injection or infusion under sterile conditions.

Research Evidence / Overview of Studies for Глатион

---

Evidence for use in studies examining Chemotherapy-Induced Nerve Symptoms

Research has explored the use of injectable Glutathione in studies examining outcomes related to certain chemotherapy treatments, particularly those involving platinum-based drugs like Cisplatin or Oxaliplatin. The primary evidence base includes Randomized Controlled Trials (RCTs) and scientific reviews that utilized comparative designs. These studies were used in research exploring how symptoms change over time and aimed to evaluate measurement of outcomes related to physical discomfort in the extremities.

Some trials reported patterns where the measured rates of severe nerve symptoms differed between the Glutathione groups and the control groups. However, patterns varied, and findings were mixed across studies that used different chemotherapy protocols. Follow-up durations were typically limited, assessing outcomes only during the active treatment phase. Furthermore, the results apply only to the specific populations studied, and studies examining other, non-platinum-based agents reported inconsistent findings.

---

Evidence for use in studies examining Liver Cell Stress

Injectable Glutathione was studied for its use in individuals facing conditions characterized by functional imbalance and cellular stress in the liver, such as chronic hepatitis or steatotic liver disease (fatty liver). The evidence landscape includes small open-label studies and pilot trials, with a more limited number of comparative trials available. Research examined the measurement of outcomes related to physiological strain by focusing on changes in liver biomarkers, such as ALT and AST enzymes.

Findings describe patterns observed in the studies, including measured shifts in specific liver enzyme levels during the study period. The evidence base has been characterized by a lack of comparative, large-scale studies needed for insight into outcomes across the broad spectrum of liver pathologies. Existing studies frequently have small sample sizes and short follow-up durations (typically weeks), limiting insight into long-term functional stability.

---

Research Gaps and Areas of Scientific Uncertainty

For all indications, the available research primarily captures data regarding short-term changes and outcomes related to episodic symptom patterns. There is limited information for long-term outcomes, and long-term effects are not fully established. Research currently has limited data regarding the durability of any measured changes or the maintenance of functional status over many years. Data for certain groups, such as pediatric patients or pregnant individuals, remains insufficient in core regulatory evidence summaries.

Key Studies & References

1. Combination Therapy with Glutathione Shows Promise in Hepatitis B Treatment

Common questions about Глатион (FAQ)

---

Q: How long is the treatment course for Glathion usually?

According to official administration guidelines, the duration of Glathion treatment is always defined by specific, time-limited courses or cycles, rather than continuous use. For its approved use as an adjunct to chemotherapy, the length of the treatment course is directly linked to the primary chemotherapy regimen being received.

---

Q: Which medicines should not be taken with Glathion?

Official drug documentation does not provide a universal list of 'do not combine' restrictions for Glathion. However, regulatory sources note clinically relevant interactions with the anticancer drug Cisplatin and the pain reliever Acetaminophen (Paracetamol), which may affect how the medicine works in the body.

---

Q: Does Glathion affect laboratory test results?

Regulatory documents state that the medicine’s use may be associated with changes in certain biological markers. Specifically, official information notes that Glathion can impact the levels of certain liver enzymes (ALT and AST), which are often monitored during therapy. The long-term use of Glutathione has also been associated with effects on zinc levels in the body.

---

Q: Why is Glathion popular among certain patient groups?

Glathion is officially approved for use as an adjunct in specific medical treatments, such as reducing nerve symptoms associated with cisplatin chemotherapy. However, regulatory bodies like the FDA have issued explicit public health warnings against the unsafe and unapproved use of injectable Glutathione for cosmetic purposes, such as skin lightening.

---

Q: What are the different dosage forms of Glathion (tablets, capsules, solution)?

The official, prescription medicine Glathion is supplied only as a sterile powder (lyophilizate) that must be mixed into a solution for injection or infusion. This preparation is strictly for parenteral use (IV or IM injection) by a healthcare professional. Other forms, such as tablets or capsules, are not included in the official regulatory documentation for this prescription product.

---

Q: Can Glathion be taken with alcohol?

While official drug documentation does not typically include a specific 'Alcohol Warning' section for this medicine, the substance is known to be involved in the metabolic process of alcohol clearance. Some studies suggest that acute alcohol consumption may deplete the body's natural Glutathione reserves.

---

Q: Is it true that Glathion can affect sleep?

The official product information does not list common side effects related to sleep disturbances (like insomnia or somnolence). However, some clinical reports of adverse reactions have mentioned sleep disturbances as a potential, though rare, side effect.

---

Q: Why is Glathion only available by prescription?

The medicine is prescription-only because it is strictly administered by a qualified healthcare professional via a controlled intravenous (IV) infusion or intramuscular (IM) injection. Its administration requires sterile preparation and specific medical supervision defined by regulatory protocols.

---

Q: Does the Glathion dose need to be adjusted for the elderly?

Official dosing instructions primarily focus on standard adult doses or calculation based on body surface area (BSA) for certain protocols. Regulatory documents do not typically specify a mandatory dose adjustment for older age alone. Specific dosage decisions always depend on the patient’s overall health status.

---

Q: Does Glathion affect the ability to drive a car?

The medicine may cause certain side effects, such as dizziness (lightheadedness) or fatigue, which could potentially impair attention. The presence of these side effects suggests that performing tasks requiring concentration, such as driving or operating machinery, may require individual caution.

---

Q: Does Glathion require specific laboratory tests for monitoring its use?

There are no specific laboratory tests required solely to monitor the intake of Glathion itself. However, because its use involves metabolic and detoxifying pathways, its administration is accompanied by monitoring of certain biomarkers, particularly liver enzyme levels, and clinical outcomes related to the primary medical condition.

---

Q: Can Glathion cause a headache?

Yes, regulatory documentation lists headache as a potential side effect. This reaction is generally considered mild and may occur after the injection is administered.

Official Storage and Disposal Requirements

Regulatory documents define strict conditions for the storage and disposal of this sterile injectable product to ensure stability and public safety.

Requirement Area	Official Constraints
Unopened Vial Storage	The powder must be stored in a cool, dry place, often specified as below 30 C or under refrigeration (2 C to 8 C). The vial must remain in its original carton to protect the contents from light.
Reconstitution Stability	Once the powder is mixed into a solution, its shelf life is limited. The solution must be used promptly or stored under refrigeration, with stability periods strictly defined on the label (e.g., use within 3 hours at room temperature).
Handling Prohibition	The reconstituted solution must not be frozen; freezing renders the product unusable and requires immediate disposal.
Disposal Instructions	Unused or expired medication must not be flushed down the toilet or discarded in household trash. Disposal must follow federal, state, and local regulations, such as authorized take-back programs.
Sharps Disposal	All used needles and syringes must be placed immediately into a puncture-proof sharps container and handled according to required procedures.
Child Safety	Like all prescription medicines, the product must be stored out of the sight and reach of children.